(Q35125396)

6 August 2017

title

Mississippi mud no more: cost-effectiveness of pharmacokinetic dosage adjustment of vancomycin to prevent nephrotoxicity (English)

1 reference

cost-effectiveness analysis

6 August 2017

main subject

1 reference

0 references

1 reference

William Darko

1

1 reference

6 August 2017

Joseph J Medicis

2

1 reference

6 August 2017

Adrienne Smith

3

1 reference

6 August 2017

Roy Guharoy

4

1 reference

6 August 2017

David E Lehmann

5

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

23

1 reference

6 August 2017

issue

5

1 reference

6 August 2017

page(s)

643-650

1 reference

Vancomycin treatment of bacteremia caused by oxacillin-resistant Staphylococcus aureus: comparison with beta-lactam antibiotic treatment of bacteremia caused by oxacillin-sensitive Staphylococcus aureus.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.643.32199

Antibiotic treatment of febrile episodes in neutropenic cancer patients. Clinical and economic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.643.32199

An updated comparison of drug dosing methods. Part IV: Vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.643.32199

Monitoring serum vancomycin levels: climbing the mountain because it is there?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.643.32199

Cost-effectiveness analysis of serum vancomycin concentration monitoring in patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.643.32199

Mild nephrotoxicity associated with vancomycin use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.643.32199

Mississippi mud in the 1990s: risks and outcomes of vancomycin-associated toxicity in general oncology practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.643.32199

Nephrotoxicity of vancomycin, alone and with an aminoglycoside

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.643.32199

Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.643.32199

A comparative assessment of vancomycin-associated nephrotoxicity in the young versus the elderly hospitalized patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.643.32199

Serum Vancomycin Concentrations: Reappraisal of Their Clinical Value

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.643.32199

10.1592/PHCO.23.5.643.32199

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference